VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CCMConcord Medical Services Holdings Limited
$5.32$774672
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCCMP/E History

CCM logoConcord Medical Services Holdings Limited (CCM) P/E Ratio History

Deep Value

Trading at -0.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2013–2014

Current P/E (TTM)
-0.0x
-101% vs 5Y avg
5Y Avg P/E
1.2x
Median 1.5x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
-0.0x
Min0.8xMedian1.5xMax1.5x
TTM EPS$-1120.21
Price$5.32
Earnings YieldN/A
EPS Growth (1Y)-3.6%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 22, 2026, Concord Medical Services Holdings Limited (CCM) trades at a price-to-earnings ratio of -0.0x, with a stock price of $5.32 and trailing twelve-month earnings per share of $-1120.21.

The current P/E is 101% below its 5-year average of 1.2x. Over the past five years, CCM's P/E has ranged from a low of 0.8x to a high of 1.5x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, CCM trades at a 100% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.

Relative to the broader market, CCM trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CCM DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

CCM Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-0.0vs22.1
-100%
Below Sector
vs. S&P 500
-0.0vs24.4
-100%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -4% EPS growth (1Y)

CCM P/E vs Peers

Specialty chronic care clinics peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
USPH logoUSPHU.S. Physical Therapy, Inc.
$964M44.6--23%
AMSF logoAMSFAMERISAFE, Inc.
$589M12.7Lowest--15%
MLAB logoMLABMesa Laboratories, Inc.
$525M78.65.79+436%Best
ISRG logoISRGIntuitive Surgical, Inc.
$144B51.72.37+23%
MDT logoMDTMedtronic plc
$102B22.0-+31%
EW logoEWEdwards Lifesciences Corporation
$50B47.76.74-74%
SYK logoSYKStryker Corporation
$118B36.62.46+8%
HCA logoHCAHCA Healthcare, Inc.
$84B13.20.63Best+29%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

CCM Historical P/E Data (2013–2014)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2014 Q4Dec 31 2014$64.10$78.000.8x-29%
FY2013 Q4-$48.14$32.401.5x+29%

Average P/E for displayed period: 1.2x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

13+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CCM — Frequently Asked Questions

Quick answers to the most common questions about buying CCM stock.

What is CCM's P/E ratio?

Concord Medical Services Holdings Limited (CCM) trailing twelve-month P/E ratio is -0.0x, based on TTM diluted EPS of $-1120.21. The 5-year average P/E is 1.2x and the historical range spans 0.8x to 1.5x.

Is CCM stock overvalued or undervalued?

CCM current P/E: -0.0x. 5-year average P/E: 1.2x. Percentile: 0th.

Is CCM stock expensive?

CCM is fairly valued relative to its own history. The current P/E of -0.0x is near the 5-year average of 1.2x (0th percentile of historical range).

What is CCM's historical P/E range?

Over the past 5 years, CCM's P/E ratio has ranged from 0.8x to 1.5x, with a median of 1.5x and an average of 1.2x. The current P/E of -0.0x places the stock at the 0th percentile of this range. Full historical data spans 2013–2014.

How does CCM's P/E compare to the S&P 500?

CCM current P/E: -0.0x. S&P 500 median P/E: 24.4x.

How does CCM's valuation compare to Healthcare peers?

Concord Medical Services Holdings Limited P/E of -0.0x can be benchmarked against Healthcare peers in the comparison table on this page.

What is CCM's PEG ratio?

CCM PEG ratio is N/A, based on a P/E of -0.0x and EPS growth of -3.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is CCM's earnings yield?

CCM earnings yield is N/A, the inverse of its -0.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

CCM P/E Ratio History (2013–2014)

Quarterly valuation multiple from closing price and trailing EPS

Current0.8x
Period Avg1.2x
Range0.8x - 1.5x
Change-45%
2 quartersDec 31, 2013 - Dec 31, 2014